507 related articles for article (PubMed ID: 3266280)
81. Activation of the first component of complement.
Schumaker VN; Zavodszky P; Poon PH
Annu Rev Immunol; 1987; 5():21-42. PubMed ID: 3036181
[No Abstract] [Full Text] [Related]
82. [Current diagnostic possibilities in hereditary angioedema and acquired angioedema].
Dick W; Cullmann W
Immun Infekt; 1985 May; 13(3):113-8. PubMed ID: 3924818
[TBL] [Abstract][Full Text] [Related]
83. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
[TBL] [Abstract][Full Text] [Related]
84. Complement studies in children with treated coeliac disease after gluten challenge.
Bosch C; Becker M; Rotthauwe HW; Opferkuch W
Eur J Pediatr; 1980 Aug; 134(2):145-8. PubMed ID: 6904300
[TBL] [Abstract][Full Text] [Related]
85. [Clinical usefulness of the lupus band test].
Benoldi D; Manganelli P; Scioscioli S
G Ital Dermatol Venereol; 1987 Oct; 122(10):495-7. PubMed ID: 3327807
[No Abstract] [Full Text] [Related]
86. Genetic aspects of complement and glomerulonephritis.
Praz F; Halbwachs L; Lesavre P
Adv Nephrol Necker Hosp; 1984; 13():271-96. PubMed ID: 6089521
[No Abstract] [Full Text] [Related]
87. Acute hepatitis: significance of changes in complement components.
Charlesworth JA; Lawrence S; Worsdall PA; Roy LP; Boughton CR
Clin Exp Immunol; 1977 Jun; 28(3):496-501. PubMed ID: 891025
[TBL] [Abstract][Full Text] [Related]
88. Prevention of immune precipitation by purified classical pathway complement components.
Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
[TBL] [Abstract][Full Text] [Related]
89. Classical pathway complement activation in association with paraproteinaemia.
Naish PF; Collins C; Barratt J
Immunology; 1977 Oct; 33(4):517-21. PubMed ID: 924520
[TBL] [Abstract][Full Text] [Related]
90. [Tissue sites of the different classes of immunoglobulins and of complement factors C1q, C3, C9 and B in relation to the state of advancement of chronic bronchitis (author's transl)].
Duheille J; Puchelle E; Horsky P; Amor M; Sadoul P
Nouv Presse Med; 1979 Jun; 8(25):2109-12. PubMed ID: 471757
[No Abstract] [Full Text] [Related]
91. The effect of synthetic androgens in hereditary angioneurotic edema: alteration of C1 inhibitor and C4 levels.
Rosse WF; Logue GL; Silberman HR; Frank MM
Trans Assoc Am Physicians; 1976; 89():122-32. PubMed ID: 1020118
[No Abstract] [Full Text] [Related]
92. The prognostic value of preoperative serum immunoglobulin and complement component concentrations in patients with gastric carcinoma.
Janssen CW; Tønder O; Matre R
Acta Chir Scand; 1985; 151(1):57-61. PubMed ID: 3984657
[TBL] [Abstract][Full Text] [Related]
93. Involvement of complement in psoriasis and atopic dermatitis--measurement of C3a and C5a, C3, C4 and C1 inactivator.
Kapp A; Wokalek H; Schöpf E
Arch Dermatol Res; 1985; 277(5):359-61. PubMed ID: 3875319
[TBL] [Abstract][Full Text] [Related]
94. Complement in type 1 (insulin-dependent) diabetes.
Senaldi G; Millward BA; Hussein MJ; Pyke D; Leslie RD; Vergani D
Diabetologia; 1987 Oct; 30(10):823. PubMed ID: 3428498
[No Abstract] [Full Text] [Related]
95. Serum complement components in Henoch-Schönlein purpura.
Garcia-Fuentes M; Martin A; Chantler C; Williams DG
Arch Dis Child; 1978 May; 53(5):417-9. PubMed ID: 666358
[TBL] [Abstract][Full Text] [Related]
96. Systemic complement fixation after fractures.
Bamberger J; Freed DL; Banks AJ; Maltby B
Lancet; 1978 Feb; 1(8060):395-6. PubMed ID: 75433
[No Abstract] [Full Text] [Related]
97. Complement components, C1 activation and disease activity in SLE.
Sturfelt G; Sjöholm AG; Svensson B
Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980
[TBL] [Abstract][Full Text] [Related]
98. [Studies on relationship between complement and blood coagulation system in toxemia of pregnancy (author's transl)].
Takahashi M
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Mar; 34(3):341-50. PubMed ID: 7069248
[TBL] [Abstract][Full Text] [Related]
99. Effect of nonviable tissue and abscesses on complement depletion and the development of bacteremia.
Heideman M; Saravis C; Clowes GH
J Trauma; 1982 Jul; 22(7):527-32. PubMed ID: 6980288
[TBL] [Abstract][Full Text] [Related]
100. The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factor.
Ji YH; Matsushita M; Okada H; Fujita T; Kawakami M
J Immunol; 1988 Dec; 141(12):4271-5. PubMed ID: 3058802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
